C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d

Numerous publications have underlined the link between complement C5a and the clinical course of COVID-19. We previously reported that levels of C5a remain high in the group of severely ill patients up to 90 days after hospital discharge. We have now evaluated which complement pathway fuels the elev...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowalska, Daria, Kuźniewska, Alicja, Senent, Yaiza, Tavira, Beatriz, Inogés, Susana, López-Díaz de Cerio, Ascensión, Pio, Ruben, Okrój, Marcin, Yuste, José Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448977/
https://www.ncbi.nlm.nih.gov/pubmed/36091057
http://dx.doi.org/10.3389/fimmu.2022.946522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448977/
https://www.ncbi.nlm.nih.gov/pubmed/36091057
http://dx.doi.org/10.3389/fimmu.2022.946522

Ejemplares similares